Fig. 8.

Real-time RT-PCR for tumor-associated myeloid cells in RMM nodules (3 cm) for CCL-2 (a), CCL-5 (b), CXCL-1 (c), MMP-2 (d), MMP-9 (e), TIMP-1 (f), TIMP-2 (g), VEGFa (h) and Flt-1 (i). MHC II⁺, CD11b⁺ MHC class II⁺ cells; CD163⁺, CD11b⁺ CD163⁺ cells; CD80⁺, CD11b⁺ CD80⁺ cells; CD11c⁺, CD11b⁺ CD11c⁺ cells